Literature DB >> 31797182

Trajectories of Evidence Based Treatment for School Children with Autism: What's the Right Level for the Implementation?

Victor Lushin1,2, David Mandell3, Rinad Beidas3, Steven Marcus3, Heather Nuske3, Victor Kaploun4, Max Seidman3, Daphney Gaston3, Jill Locke5.   

Abstract

Evidence-based practices (EBP) for children with autism are under-used in special-education schools. No research compared child-level versus teacher-level influences on EBP use, which could guide implementation strategies. We derived longitudinal profiles of EBP receipt by children (N = 234) in 69 autism-support classrooms, over an academic year. We compared overall impacts of child-level and teacher-level factors on profile membership. Most children received little EBP throughout the year; however substantial subgroups received increasing, and decreasing, doses of EBP. Child-level and teacher-level factors contributed about equally to profile membership. Children's autism symptoms and verbal ability, teachers' EBP skills, training/experience, classroom support, class size, and implementation leadership climate predicted profile membership. Early identification of treatment profiles could facilitate targeted implementation strategies increasing EBP use.

Entities:  

Keywords:  Autism; Evidence based practices; Special education

Mesh:

Year:  2020        PMID: 31797182      PMCID: PMC7012711          DOI: 10.1007/s10803-019-04304-6

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  15 in total

1.  Subtypes, severity, and structural stability of peer victimization: what does latent class analysis say?

Authors:  Karen Nylund; Amy Bellmore; Adrienne Nishina; Sandra Graham
Journal:  Child Dev       Date:  2007 Nov-Dec

Review 2.  Systematic review of early intensive behavioral interventions for children with autism.

Authors:  Patricia Howlin; Iliana Magiati; Tony Charman
Journal:  Am J Intellect Dev Disabil       Date:  2009-01

3.  Pebbles, rocks, and boulders: The implementation of a school-based social engagement intervention for children with autism.

Authors:  Jill Locke; Courtney Benjamin Wolk; Colleen Harker; Anne Olsen; Travis Shingledecker; Frances Barg; David Mandell; Rinad Beidas
Journal:  Autism       Date:  2016-10-20

4.  HIV Risk Behavior among Youth in the Dominican Republic: The Role of Alcohol and Other Drugs.

Authors:  Vincent Guilamo-Ramos; James Jaccard; Viktor Lushin; Roberto Martinez; Bernardo Gonzalez; Katharine McCarthy
Journal:  J Int Assoc Physicians AIDS Care (Chic)       Date:  2011-09-12

5.  Recall bias in reporting medically unexplained symptoms comes from semantic memory.

Authors:  Jan H Houtveen; Nicole Y L Oei
Journal:  J Psychosom Res       Date:  2007-03       Impact factor: 3.006

6.  Patterns of growth in verbal abilities among children with autism spectrum disorder.

Authors:  Deborah K Anderson; Catherine Lord; Susan Risi; Pamela S DiLavore; Cory Shulman; Audrey Thurm; Kathleen Welch; Andrew Pickles
Journal:  J Consult Clin Psychol       Date:  2007-08

7.  The Utility of Measuring Intentions to Use Best Practices: A Longitudinal Study Among Teachers Supporting Students With Autism.

Authors:  Jessica Fishman; Rinad Beidas; Erica Reisinger; David S Mandell
Journal:  J Sch Health       Date:  2018-05       Impact factor: 2.118

8.  Advancing a conceptual model of evidence-based practice implementation in public service sectors.

Authors:  Gregory A Aarons; Michael Hurlburt; Sarah McCue Horwitz
Journal:  Adm Policy Ment Health       Date:  2011-01

9.  Assessing the organizational context for EBP implementation: the development and validity testing of the Implementation Climate Scale (ICS).

Authors:  Mark G Ehrhart; Gregory A Aarons; Lauren R Farahnak
Journal:  Implement Sci       Date:  2014-10-23       Impact factor: 7.327

10.  The Implementation Leadership Scale (ILS): development of a brief measure of unit level implementation leadership.

Authors:  Gregory A Aarons; Mark G Ehrhart; Lauren R Farahnak
Journal:  Implement Sci       Date:  2014-04-14       Impact factor: 7.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.